Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,416 | -20,649 | -22,681 | -14,921 | -8,399 |
| Depreciation Amortization | 296 | 1,911 | 1,550 | 1,272 | 719 |
| Income taxes - deferred | N/A | -1,239 | -178 | N/A | 0 |
| Accounts receivable | -135 | 294 | 51 | 125 | 26 |
| Other Working Capital | -1,344 | 1,301 | 2,019 | 1,076 | 588 |
| Other Operating Activity | -4,825 | -1,371 | 5,127 | 3,183 | 2,040 |
| Operating Cash Flow | $-7,424 | $-19,753 | $-14,112 | $-9,265 | $-5,026 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -41 | -22 | -16 | -10 |
| Other Investing Activity | 10,085 | 13,079 | 12,158 | 11,974 | 5,266 |
| Investing Cash Flow | $10,074 | $13,038 | $12,136 | $11,958 | $5,256 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -26 | -24 | -17 | -8 |
| Common Stock Issued | 21,590 | 5,127 | N/A | N/A | N/A |
| Common Stock Repurchased | -13 | -27 | N/A | -13 | -2 |
| Other Financing Activity | -614 | 24,791 | 25,075 | 523 | 0 |
| Financing Cash Flow | $20,963 | $29,865 | $25,051 | $493 | $-10 |
| Exchange Rate Effect | -80 | -63 | -36 | -38 | 73 |
| Beginning Cash Position | 33,183 | 10,096 | 10,096 | 10,096 | 10,096 |
| End Cash Position | 56,716 | 33,183 | 33,135 | 13,244 | 10,389 |
| Net Cash Flow | $23,533 | $23,087 | $23,039 | $3,148 | $293 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,424 | -19,753 | -14,112 | -9,265 | -5,026 |
| Capital Expenditure | -11 | -64 | -40 | -16 | -10 |
| Free Cash Flow | -7,435 | -19,817 | -14,152 | -9,281 | -5,036 |